It is well-established that a number of transcription factors are sensitive to redox alterations (e.g., Nuclear factor kappa B, NF-κB, and Nuclear factor erythroid 2-related factor 2, Nrf2); therefore, monitoring the levels of oxidative stress in cancer cells may provide information about the characteristics of the cancer [102]. The gene discussed is NFE2L2; the disease is cancer.